Madrigal Pharmaceuticals Company Description

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Madrigal Pharmaceuticals, Inc.

Country	United States
Industry	Pharmaceutical Preparations
Employees	528
CEO	William Sibold

Contact Details

Address: Four Tower Bridge West Conshohocken, Delaware 19428 United States
Phone	267 824 2827
Website	madrigalpharma.com

Stock Details

Ticker Symbol	1MDGL
Exchange	Borsa Italiana
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2834

Key Executives

Name	Position
William Sibold	Chief Executive Officer
Mardi Dier	Chief Financial Officer
Mark Underwood	Chief Operating Officer
Tina Ventura	Head of Investor Relations